John on for Andrew Tsai's questions to Axsome Therapeutics Inc (AXSM) leadership • Q2 2025
Question
An analyst from Jefferies asked about the commercial strategy for AXS-05 in long-term care facilities and what the key topics might be in a potential FDA Advisory Committee meeting.
Answer
Chief Commercial Officer Ari Maizel explained the strategy will be highly targeted, focusing on high-value prescribers. Regarding a potential AdCom, he stated there has been no indication of one, but if it were to occur, topics might include endpoints and scales used, similar to the Rexulti AdCom.